← Leaderboards
Anthony Bruce Pinkerton
Sanford Burnham Prebys Medical Discovery Institute
$3,967,668
Attributed
$6,082,835
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2015–19$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$6,082,835 · 4
By mechanism
R01$4,230,335 · 2
R33$1,462,500 · 1
R21$390,000 · 1
Top collaborators
- Nunzio Bottini6 shared
- Michael Jackson3 shared
Most similar at Sanford Burnham Prebys Medical Discovery Institute
Same institution · by research overlap
- Steven H Olson$9,813,239
- Lutz Tautz$6,319,255
- Vladislav Golubkov$96,038
- Caroline Kumsta$1,697,717
- Andrei L Osterman$14,236,902
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadDesignRodentAnalogIn VivoOralIn VitroBaseMedicalPre-ClinicalPropertyPermeabilityDoseInhibitor/AntagonistDrug KineticsUnited States National Institutes Of HealthChemistryMolecularMortalityAnimal ModelMediatingAbsorptionExcretory FunctionMetabolism
Grant awards (13)
Small molecule inhibitors of LMPTP: an obesity drug target$518,066
R01 · FY2019 · DK
Lead optimization of brain penetrant Neurotensin Receptor 1 agonists$487,500
R33 · FY2018 · DA · contact PI
Optimization of glucocorticoid receptor (GR) passive antagonists for the treatment of post-traumatic stress disorder (PTSD)$459,360
R01 · FY2018 · MH · contact PI
Small Molecule Inhibitors of LMPTP: An Obesity Drug Target$287,046
R01 · FY2018 · DK
Optimization of glucocorticoid receptor (GR) passive antagonists for the treatment of post-traumatic stress disorder (PTSD)$635,352
R01 · FY2017 · MH · contact PI
Small Molecule Inhibitors of LMPTP: An Obesity Drug Target$511,636
R01 · FY2017 · DK
Lead optimization of brain penetrant Neurotensin Receptor 1 agonists$487,500
R33 · FY2017 · DA · contact PI
Optimization of glucocorticoid receptor (GR) passive antagonists for the treatment of post-traumatic stress disorder (PTSD)$611,804
R01 · FY2016 · MH · contact PI
Lead optimization of brain penetrant Neurotensin Receptor 1 agonists$487,500
R33 · FY2016 · DA · contact PI
Small Molecule Inhibitors of LMPTP: An Obesity Drug Target$423,964
R01 · FY2016 · DK
Small Molecule Inhibitors of LMPTP: An Obesity Drug Target$149,215
R01 · FY2016 · DK
Small Molecule Inhibitors of LMPTP: An Obesity Drug Target$633,892
R01 · FY2015 · DK
Lead optimization of brain penetrant Neurotensin Receptor 1 agonists$390,000
R21 · FY2015 · DA · contact PI